Insider · CIK 0002005875

Hughes-Wilson Alexandra

Reports to the SEC for 1 company · LONDON, X0

sec.gov

Transactions

Companies

Filings

CIK

0002005875

Forms 4 and 5

Insider transactions

27 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-01	MREOMereo BioPharma Group plc · Share Options (Right to buy)A Award	See Remarks	AAward	+184K sh	—	—	183,750
2026-02-01	MREOMereo BioPharma Group plc · Share Options (Right to buy)A Award	See Remarks	AAward	+61.3K sh	—	—	61,250
2026-02-01	MREOMereo BioPharma Group plc · Share Options (Right to buy)A Award	See Remarks	AAward	+195K sh	—	—	195,000
2025-01-25	MREOMereo BioPharma Group plc · Share Options (Right to buy)A Award	See Remarks	AAward	+154K sh	—	—	154,000
2024-09-13	MREOMereo BioPharma Group plcS Sale	See Remarks	SSale	−16.3K sh	$4.22	−$68.8K	134,483
2024-09-13	MREOMereo BioPharma Group plcS Sale	See Remarks	SSale	−84K sh	$4.22	−$355K	50,475
2024-09-12	MREOMereo BioPharma Group plcS Sale	See Remarks	SSale	−7,769 sh	$4.47	−$34.7K	190,816
2024-09-12	MREOMereo BioPharma Group plcS Sale	See Remarks	SSale	−40K sh	$4.47	−$179K	150,787
2024-09-11	MREOMereo BioPharma Group plcM Exercise/Conversion	See Remarks	MExercise/Conversion	+40K sh	—	—	74,548
2024-09-11	MREOMereo BioPharma Group plcM Exercise/Conversion	See Remarks	MExercise/Conversion	+93.3K sh	$1.40	+$131K	167,881
2024-09-11	MREOMereo BioPharma Group plcM Exercise/Conversion	See Remarks	MExercise/Conversion	+75K sh	$1.01	+$75.8K	242,881
2024-09-11	MREOMereo BioPharma Group plc · Performance Based Restricted Stock UnitM Exercise/Conversion	See Remarks	MExercise/Conversion	−40K sh	—	—	0
2024-09-11	MREOMereo BioPharma Group plc · Share Options (Right to buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−93.3K sh	$1.40	−$131K	0
2024-09-11	MREOMereo BioPharma Group plc · Share Options (Right to buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−75K sh	$1.01	−$75.8K	0
2024-06-26	MREOMereo BioPharma Group plcS Sale	See Remarks	SSale	−23K sh	$3.39	−$77.9K	34,548
2024-06-25	MREOMereo BioPharma Group plcS Sale	See Remarks	SSale	−10.1K sh	$3.69	−$37.4K	57,516
2024-06-21	MREOMereo BioPharma Group plcM Exercise/Conversion	See Remarks	MExercise/Conversion	+60K sh	—	—	67,650
2024-06-21	MREOMereo BioPharma Group plc · Performance Based Restricted Stock UnitM Exercise/Conversion	See Remarks	MExercise/Conversion	+60K sh	—	—	40,000
2024-05-22	MREOMereo BioPharma Group plcM Exercise/Conversion	See Remarks	MExercise/Conversion	+93.3K sh	$1.40	+$131K	100,983
2024-05-22	MREOMereo BioPharma Group plcS Sale	See Remarks	SSale	−50.4K sh	$2.99	−$151K	58,633
2024-05-22	MREOMereo BioPharma Group plcF Tax Payment	See Remarks	FTax Payment	−43K sh	$1.40	−$60.2K	7,650
2024-05-22	MREOMereo BioPharma Group plcM Exercise/Conversion	See Remarks	MExercise/Conversion	+75K sh	$1.01	+$75.8K	82,650
2024-05-22	MREOMereo BioPharma Group plcS Sale	See Remarks	SSale	−50.1K sh	$2.94	−$147K	32,568
2024-05-22	MREOMereo BioPharma Group plcF Tax Payment	See Remarks	FTax Payment	−24.9K sh	$1.01	−$25.2K	7,650
2024-05-22	MREOMereo BioPharma Group plc · Share Options (Right to buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−93.3K sh	$1.40	−$131K	0
2024-05-22	MREOMereo BioPharma Group plc · Share Options (Right to buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−75K sh	$1.01	−$75.8K	0
2024-01-25	MREOMereo BioPharma Group plc · Share Options (Right to buy)A Award	See Remarks	AAward	+196K sh	—	—	196,000

Recent filings

Accepted (ET)
Feb 24
Hughes-Wilson Alexandra0001193125-26-033753
SEC(opens sec.gov)
Jan 284
Hughes-Wilson Alexandra0000950170-25-009789
SEC(opens sec.gov)
Sep 164
Hughes-Wilson Alexandra0000950170-24-106968
SEC(opens sec.gov)
Sep 134
Hughes-Wilson Alexandra0000950170-24-106413
SEC(opens sec.gov)
Jun 274
Hughes-Wilson Alexandra0000950170-24-078462
SEC(opens sec.gov)
Jun 254
Hughes-Wilson Alexandra0000950170-24-077479
SEC(opens sec.gov)
May 234
Hughes-Wilson Alexandra0000950170-24-064274
SEC(opens sec.gov)

Companies

Mereo BioPharma Group plcSee RemarksMREO

Address

C/O MEREO BIOPHARMA GROUP PLC 4TH FLOOR, ONE CAVENDISH PLACE

LONDON, X0, W1G 0QF